Text to be removed highlighted in red.
1 New Subdivision; Copayment Reimbursement. Amend RSA 161-L by inserting after section 7 the following new subdivision:
Copayment Reimbursement
161-L:8 CoPayment Reimbursement Prohibited.
I. No prescription drug manufacturer doing business in New Hampshire shall establish a copayment reimbursement program or otherwise offer to pay, waive, or reimburse a patient for his or her insurance copayment.
II. This section shall apply to copayments required under any health insurance plan offered by a public or private entity.
III. Any person found in violation of this section shall be guilty of a violation.
2 Effective Date. This act shall take effect January 1, 2018.
Text to be added highlighted in green.
1 New Subdivision; Copayment Reimbursement. Amend RSA 161-L by inserting after section 7 the following new subdivision:
Copayment Reimbursement
161-L:8 CoPayment Reimbursement Prohibited.
I. No prescription drug manufacturer doing business in New Hampshire shall establish a copayment reimbursement program or otherwise offer to pay, waive, or reimburse a patient for his or her insurance copayment.
II. This section shall apply to copayments required under any health insurance plan offered by a public or private entity.
III. Any person found in violation of this section shall be guilty of a violation.
2 Effective Date. This act shall take effect January 1, 2018.